Real-time enrollment status for this kras mutant solid tumors clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:37 AM UTC
| NCT Number | NCT07204340 |
| Recruiting Status | Recruiting |
| Condition | KRAS Mutant Solid Tumors |
| Phase | Clinical Trial |
| Target Enrollment | 240 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Treeline Biosciences, Inc. |
| Last Updated on CT.gov | April 21, 2026 (Apr 21, 2026) |
As of July 13, 2026: Clinical trial NCT07204340 is currently recruiting participants. This clinical trial study for kras mutant solid tumors is actively seeking new participants at 6 locations across the United States. The study is sponsored by Treeline Biosciences, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07204340 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07204340 was last updated Apr 21, 2026 (April 21, 2026). HelloStudys verifies this status automatically.